+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 45Years - 75Years
FEMALE
Healthy Volunteers
ID04891029

Phase III Study Testing a New Genomic Uterine Pap Test for Early Detection of Endometrial and Ovarian Cancer and Cancer Risk

Led by McGill University · Updated on 2025-06-17

5600

Participants Needed

2

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new genomic test called the DOvEEgene test for early detection of ovarian and endometrial cancers in women aged 45 to 75. These cancers often show no symptoms until advanced stages, making early diagnosis challenging. The test aims to identify cancer-related genetic mutations in uterine samples and detect hereditary cancer risks using saliva samples, potentially improving early diagnosis compared to current methods like ultrasound and blood tests. Participants will undergo the DOvEEgene genomic uterine pap test along with standard clinical tests such as CA-125 blood tests and transvaginal ultrasounds for comparison. This phase III diagnostic trial follows previous studies that showed promising results in detecting these cancers earlier in surgical patients. The study will last three years to assess the tests accuracy and usefulness in a general population of peri- and post-menopausal women. During the study, women will provide uterine and saliva samples and complete evaluations related to their experience and quality of life. Researchers will monitor early cancer diagnosis rates and identify germline mutations linked to hereditary cancer risks. The study also examines the impact of participation on quality of life and the costs of any unnecessary medical interventions. Participants will be followed for three years to capture these outcomes.

CONDITIONS

Brief Title

Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers

Research Team

L

Lucy Gilbert, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here